-Announcement for the purposes of Rule 2.8 of the Irish Takeover Panel Act, 1997, Takeover Rules, 2022 (the “Irish Takeover Rules”)-BLUETTI Opens First Flagship Store in Munich, Germany for Hands-on Experience-10 Trucos para ahorrar en la factura de la luz en España-Leading Solo VC Ozi Amanat Collects $300 Million-Jack Nathan Health Provides Corporate Update-CORRECTING and REPLACING – Canadian Spirit Resources Inc. Announces Third Quarter 2022 Financial Results-Friedman Industries, Incorporated Announces Second Quarter Results and Provides Near-term Outlook-Wesco Declares Quarterly Dividend on Preferred Stock-InterDigital Declares Regular Quarterly Cash Dividend-BeeHero Raises $42 Million Series B to Accelerate Deployment of Its Data-driven Precision Pollination Platform-Athene Holding Ltd. Declares Fourth Quarter 2022 Preferred Stock Dividends-Horace Mann declares quarterly dividend-PotlatchDeltic Board Declares $0.95 Special Dividend and Increases Regular Distribution 2.3%-FCPT Announces Acquisition of a Cheesecake Factory Property and a Dual-tenant Starbucks and AT&T Property for $12.3 Million-EVERTEC Announces Refinancing of Credit Facilities-Brookfield Office Properties Announces Reset Dividend Rate and Conversion Privileges on Its Class AAA Series II Preference Shares-CORRECTING and REPLACING Essential Utilities’ Aqua Illinois Subsidiary Acquires Oak Brook Water Assets-Correction: KOREA FAIR TRADE COMMISSION (KFTC) – APPEAL PROCEEDINGS UPDATE-KOREA FAIR TRADE COMMISSION (KFTC) – POINT SUR LA PROCEDURE D’APPEL-Korea Fair Trade Commission (kftc) – Appeal Proceedings Update

C.A.M.P Brings New Hope to Alzheimer’s and Dementia Patients

C.A.M.P Brings New Hope to Alzheimer’s and Dementia Patients

Carson City, NV, March 17, 2022 –(PR.com)– CAMP: Cognitive Assessment & Memory Program, announced the recent research findings for their neuro-digital health platform. Findings show improvements in cognition for patients with mild to moderate cognitive impairment.

“As many as 91% of patients around the world who suffer from cognitive impairment go undiagnosed. This is due to the lack of mainstream screening and preventative care. CAMP seeks to evolve the process of early detection and treatment.,” said Jeb Andrews, CEO of CAMP. “Our program is a revolutionary approach that is changing the lives of patients and caregivers every day while providing physicians a simpler approach to screening and treatment.”

The study found that seniors with mild to moderate cognitive impairment experienced statistically significant improvements in their cognitive function, sleep, depression, and anxiety levels. These findings serve as initial evidence for the overall feasibility and effectiveness of the CAMP program which could potentially help more than 6 million Americans once nationally launched.

“Until now there has been no readily available assessment and treatment for these early cases of Alzheimer’s, dementia, and age-related memory loss. We are pushing into the next phase to ensure that this treatment is available to all patients in need, in the comfort of their home, with little to no cost to the patient,” said Jeb.

Learn More About CAMP

To learn more about CAMP, you can visit the following page/website:


CAMP Contact Information:




Mollie Cline






Leave a Comment